Tower Research Capital LLC (Trc) Bausch Health Companies Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,583 shares of BHC stock, worth $115,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,583

Previous 2,963 425.92%

Holding current value

$115,158

Previous $20,000 535.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $65,876 - $104,241	12,620 Added 425.92%	15,583 $127,000
Q2 2024 Aug 13, 2024	BUY	$6.1 - $10.41 $536 - $916	88 Added 3.06%	2,963 $20,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $31,414 - $42,896	-4,043 Reduced 58.44%	2,875 $30,000
Q4 2023 Feb 13, 2024	BUY	$6.53 - $8.23 $33,381 - $42,071	5,112 Added 283.06%	6,918 $55,000
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $78,914 - $99,644	-10,262 Reduced 85.03%	1,806 $14,000
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $63,308 - $97,398	11,068 Added 1106.8%	12,068 $96,000
Q1 2023 May 09, 2023	SELL	$6.28 - $9.85 $169,434 - $265,753	-26,980 Reduced 96.43%	1,000 $8,000
Q4 2022 Feb 10, 2023	SELL	$6.09 - $7.93 $175,763 - $228,867	-28,861 Reduced 50.77%	27,980 $176,000
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $90,702 - $182,394	19,804 Added 53.47%	56,841 $396,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $194,884 - $652,282	-27,604 Reduced 42.7%	37,037 $310,000
Q1 2022 May 12, 2022	BUY	$21.6 - $27.79 $991,893 - $1.28 Million	45,921 Added 245.3%	64,641 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $2,622 - $3,307	114 Added 0.61%	18,720 $514,000
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $96,704 - $116,091	-3,862 Reduced 17.19%	18,606 $515,000
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $37,387 - $44,570	1,363 Added 6.46%	22,468 $659,000
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $40,581 - $65,287	1,899 Added 9.89%	21,105 $666,000
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $271,859 - $375,027	-17,757 Reduced 48.04%	19,206 $398,000
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $253,049 - $342,330	17,006 Added 85.21%	36,963 $572,000
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $203,589 - $313,720	-15,296 Reduced 43.39%	19,957 $365,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $217,376 - $506,596	16,747 Added 90.49%	35,253 $547,000
Q4 2019 Feb 07, 2020	SELL	$18.89 - $31.89 $389,984 - $658,369	-20,645 Reduced 52.73%	18,506 $550,000
Q3 2019 Nov 05, 2019	BUY	$20.88 - $25.66 $385,131 - $473,298	18,445 Added 89.08%	39,151 $855,000
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $299,612 - $386,196	14,601 Added 239.16%	20,706 $523,000
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $121,501 - $157,897	-6,006 Reduced 49.59%	6,105 $150,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $179,063 - $287,476	10,151 Added 517.91%	12,111 $224,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $40,454 - $50,313	1,960 New	1,960 $50,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Bausch Health Companies Inc. Transaction History